Suppr超能文献

HSV-2 原发性感染致致命性感染:病例报告。

Fatal HSV-2 primary infection most likely acquired by kidney transplantation: A case report.

机构信息

Laboratoire de Virologie, CHU Grenoble Alpes, Grenoble, France; Institut de Biologie Structurale, UMR 5075 CEA-CNRS-Université Grenoble-Alpes, Grenoble, France.

Service de Néphrologie, Hémodialyse, Aphérèses et Transplantation, CHU Grenoble Alpes, Grenoble, France.

出版信息

Int J Antimicrob Agents. 2023 May;61(5):106769. doi: 10.1016/j.ijantimicag.2023.106769. Epub 2023 Mar 3.

Abstract

Herpes simplex virus 2 (HSV-2) rarely causes severe disease, even in solid organ transplant recipients. This paper describes a fatal case of HSV-2 infection, probably transmitted from a donor to a kidney transplant recipient. The donor was seropositive for HSV-2 but not for HSV-1, whereas the recipient was seronegative for both viruses before transplantation, suggesting that the graft was the source of infection. The recipient received valganciclovir prophylaxis due to cytomegalovirus seropositivity. Three months after transplantation, the recipient presented with rapidly disseminated cutaneous HSV-2 infection with meningoencephalitis. The HSV-2 strain was resistant to acyclovir, probably acquired under valganciclovir prophylaxis. Despite early initiation of acyclovir therapy, the patient died. This fatal case of HSV-2 infection, probably transmitted by the kidney graft with acyclovir-resistant HSV-2 from the onset, is uncommon.

摘要

单纯疱疹病毒 2 型(HSV-2)很少引起严重疾病,即使在实体器官移植受者中也是如此。本文描述了一例 HSV-2 感染的致死病例,可能是由供体传播给肾移植受者。供体血清 HSV-2 阳性但 HSV-1 阴性,而受者移植前两种病毒均为阴性,提示移植物是感染源。由于巨细胞病毒血清阳性,受者接受缬更昔洛韦预防。移植后 3 个月,受者出现迅速播散性皮肤 HSV-2 感染伴脑膜脑炎。HSV-2 株对阿昔洛韦耐药,可能是在缬更昔洛韦预防下获得的。尽管早期开始阿昔洛韦治疗,患者仍死亡。本例 HSV-2 感染致死病例,可能是由肾移植供体携带的、从发病开始就对阿昔洛韦耐药的 HSV-2 传播引起的,较为罕见。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验